| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0005 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0006 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0008 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |